Clinical trial
SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II…
NCT00002495 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00002495 |
|---|---|
| Title | SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease |
| Official title | Randomized Trial of Subtotal Nodal Irradiation Versus Doxorubicin, Vinblastine and Subtotal Nodal Irradiation for Stage I-IIA Hodgkin's Disease |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | doxorubicin hydrochloride, vinblastine, standard subtotal nodal irradiation |
| Enrollment | 348 |
| Start date | Sep 1, 1992 |
| Primary completion | Nov 1, 2000 |
| Completion | Apr 1, 2014 |
| First posted | Jul 19, 2004 |
| Last update posted | Feb 20, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: